EMIT Imaging

EMIT Imaging, Inc. is a biotechnology company based in Baltimore, MD, specializing in Cryo-Fluorescence Tomography (CFT). This advanced 3D imaging technology is designed for preclinical research, providing high-resolution and high-sensitivity insights into biological samples. EMIT's flagship platform, Xerra™, enables whole-body visualization of drug distribution, protein expression, and biochemical processes.

The CFT technique involves freezing biological samples, acquiring detailed images, and generating 3D image stacks. This method offers comprehensive data for applications in gene and cell therapy, neuroscience, and oncology, enhancing research in drug development and therapeutic protein studies. EMIT provides state-of-the-art CFT instrumentation for purchase and offers fee-for-service research at its labs in Boston and Baltimore, where customers can send samples for analysis.

EMIT collaborates with pharmaceutical, biotechnology, and academic researchers globally, including partnerships with institutions like the MIT Koch Institute for Integrative Cancer Research. Under the leadership of CEO Dr. Matthew Silva, EMIT aims to lead in the field of CFT and drive innovation in biological and medical research.